Skip to main content
. 2019 Mar 15;17(6):4928–4934. doi: 10.3892/ol.2019.10150

Figure 4.

Figure 4.

Effects of NEF overexpression on expression levels of β-catenin in the human LSCC cell line UM-SCC-17A. (A) Effects of NEF overexpression on expression levels of β-catenin. (B) Effects of Wnt agonist on NEF expression in the human LSCC cell line UM-SCC-17A. NEF expression levels were normalized to β-actin (endogenous control). *P<0.05. C, control; LSCC, laryngeal squamous cell carcinoma; NC, negative control (empty vector transfection); NEF, neighboring enhancer of FOXA2.